Submissions Open for Special Issue of Vaccines on Estimating Vaccines’ Value and Impact

Estimating the value and public health impact of vaccines is critical to ensure evidence-based policy decision making in nearly all stages, from vaccine development to the introduction/implementation of vaccines in low-resource settings. To foster public health equity, as well as estimate value to local and national economies, concerted efforts are needed to increase the understanding of the full value of vaccination. Such value goes beyond direct disease prevention and can, for example, include impacts on the life course of vaccinated recipients, on the wider community, and on entire health systems.

We are pleased to invite you to contribute with your research work to provide readers (e.g., member states, global policymakers, funding entities, and/or the vaccine R&D community) with insights on how the “full” value of vaccines can be assessed or was assessed by you. This can be carried out through concrete assessments that you undertook or by offering methodological advice that can help the growing community of researchers and implementers to inform as well as optimize responses to vaccine-preventable diseases.

In this Special Issue, original research articles and reviews are welcome. Research areas may include (but not limited to) the following:

  • Reviews
    • Full value of vaccine assessment concept and approaches;
    • Current estimation of value in the vaccine space and areas for improvement as well as expansion (e.g., equity, broader perspectives, etc.);
    • Standardization of methods to support robust assessments of the impact as well as value of vaccines.
  • Original research articles on
    • Full value of vaccine assessments;
    • Impact assessment of vaccination in low-resource settings;
    • Efforts to support policy decision making on vaccine introduction/prioritzation.

Learn more about submissions, including deadlines and information on where to submit, here.

You May Also Like

Delivering 270M+ COVID-19 vaccines at just $0.29 per dose: The Bangladesh experience

Bangladesh launched its COVID-19 vaccination program in February 2021 with the ambitious aim of reaching 80% of the population with two doses. The program used a phased approach, initially targeting priority groups, and expanding eligibility over time as supply ramped up. By June 2022, the country had achieved its goal—having delivered over 270 million COVID-19 … Read More

Call for resources: ThinkWell is inviting researchers to submit evidence on the cost of delivering immunization services

The Immunization Delivery Cost Catalogue (IDCC) is the most comprehensive, standardized global evidence on the cost of delivering vaccines, covering 317 unit costs from 68 studies published between 2005 and early 2019. The IDCC supports global and country immunization stakeholders in answering the question: “What are the unit costs of vaccine delivery across different low … Read More

New evidence on the costing the delivery of COVID-19 vaccines in Mozambique and the Philippines

ThinkWell has released two new reports on the cost of delivering COVID-19 vaccines in Mozambique and the Philippines, aiming to support governments and address the knowledge gap on the cost of these vaccination programs. In partnership with the Universidade Eduardo Mondlane and Ateneo de Manila University, ThinkWell conducted retrospective, bottom-up costing studies, as well as … Read More